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The receptor tyrosine kinase Ret (c-Ret) transduces the glial cell line-derived neurotrophic factor (GDNF) signal, one of the
neurotrophic factors related to the degeneration process or the regeneration activity of motor neurons in amyotrophic lateral
sclerosis (ALS). The phosphorylation of several tyrosine residues of c-Ret seems to be altered in ALS. c-Ret is expressed in motor
neurons and in the enteric nervous system (ENS) during the embryonic period. The characteristics of the ENS allow using it as
model for central nervous system (CNS) study and being potentially useful for the research of human neurological diseases such
as ALS. The aim of the present study was to investigate the cellular localization and quantitative evaluation of marker c-Ret in the
adult human gut. To assess the nature of c-Ret positive cells, we performed colocalization with specificmarkers of cells that typically
are located in the enteric ganglia. The colocalization of PGP9.5 and c-Ret was preferentially intense in enteric neurons with oval
morphology and mostly peripherally localized in the ganglion, so we concluded that the c-Ret receptor is expressed by a specific
subtype of enteric neurons in the mature human ENS of the gut. The functional significance of these c-Ret positive neurons is
discussed.
1. Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenera-
tive disease characterized by selective degeneration of motor
neurons located in the spinal cord, brain stem, and motor
cortex, resulting in progressive atrophy and paralysis of limb,
bulbar, and respiratory muscles [1–5]. Glial cell line-derived
neurotrophic factor (GDNF) has been thought to be one of
the potent neurotrophic factors related to the degeneration
process or the regeneration activity of motor neurons in
ALS. In particular GDNF is a member of the transforming
growth factor-𝛽 superfamily which promotes the survival
of motor neurons and mesencephalic dopaminergic neurons
[6, 7]. The GDNF signal is transduced by a specific receptor,
the proto-oncogene product RET (a tyrosine kinase recep-
tor c-Ret), in association with another receptor GDNFR-𝛼
(GFR𝛼-1) [6, 8–12]. The phosphorylation of several tyrosine
residues of RET is a crucial step in the intracellular signaling
pathway [6, 13] and it seems to be altered in ALS [5]. c-Ret is
expressed in the restricted tissues including motor neurons
determining the specific distribution of GDNF-responsive
neurons, [12]; one of these tissues is the enteric nervous
system (ENS) where Ret is highly expressed during the
embryonic period. It is a crucial signal for the development
of enteric neurons [14–19].
On the other hand, the enteric nervous system (ENS)
is a collection of neurons in the gastrointestinal tract that
constitutes the “brain of the gut.” This system provides
neural control for all functions of the gastrointestinal tract.
Subsequent examination of the functional and chemical
diversity of enteric neurons revealed that the enteric nervous
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system closely resembles the central nervous system (CNS).
In fact, the ultrastructure of the ENS is more similar to
the CNS ultrastructure than to the rest of the peripheral
nervous system (PNS) [20, 21]. Interestingly, gut and brain
can show a parallel pathology in most neurodegenerative
diseases [22]. In connection with ALS, the tight association
between ALS and ENS was firstly described by Sanchez and
collaborators, when the generation of GDNFmutantmice led
to massive loss of ENS neurons [23]. These characteristics
lead researchers to develop ENS as model for CNS study
and being potentially useful for the research of human
neurological diseases such as ALS. Moreover, recent studies
in an animal model of ALS (TDP-43 A315T transgenic
mice) showed a lack of severe muscle atrophy or external
muscle weakness in later stages of the disease although
degeneration of myenteric neurons by the accumulation of
TDP-43 was detected. Rather than severe muscle weakness,
the progressively thinned colon contributed to the death
of the transgenic mice [24]. For this reason, it would be
interesting to study and provide additional information on
the location of c-Ret in gastrointestinal human samples in
order to extrapolate to ALS patients, for better understanding
of the disease and the possible identification of targetmarkers
of disease.
The ENS arises from two regions of the neural crest: the
vagal neural crest which gives rise to the vast majority of
enteric neurons throughout the gastrointestinal tract and the
sacral neural crest which contributes a smaller number of
cells that are mainly distributed within the hindgut.
Neural crest cells (NCCs) migrate and differentiate into
a variety of cell lineages such as melanocytes, neurons, glial
cells, myofibroblasts, chondrocytes, and osteoblasts [25–28].
Some of the migrating NCCs are multipotent [29] and they
maintain their nature at the time they reach the foregut
mesenchyme [30–32]. Once within the gut, these enteric
neural crest stem cells (eNCSCs) generate a vast array of
phenotypically diverse neurons and glial cells. Furthermore,
differentiation of eNCSCs is asynchronous and therefore
multipotent progenitor cells coexist with differentiated cell
types [30].
A number of markers have become available that label
migratory or post- migratory NCCs within the gastrointesti-
nal tract of embryonic mice and rats. Previous studies have
shown that undifferentiated enteric crest-derived cells are
Phox2b(+)/c-Ret(+)/p75(+)/Sox10(+) [33].
c-Ret is expressed during embryogenesis on various
neuronal subsets of the central and peripheral nervous
system and it is crucial for the development of sympathetic,
parasympathetic, motor, and sensory neurons. Furthermore,
c-Ret is necessary for the postnatal maintenance of dopamin-
ergic neurons, but it also regulates also the development
of the nervous plexuses of the entire intestinal tract [14,
18, 19, 34]. Mutations in c-Ret, albeit drastically, affect only
a subset of peripheral nervous system ganglia. Thus, loss
of c-Ret function in humans can lead to congenital mega-
colon (Hirschsprung’s disease), a condition characterized by
absence of enteric ganglia [35–37], which demonstrates its
important role in the enteric neurogenesis.
Due to the fact that there are no immunohistochemical
studies on the presence of c-Ret in the normal adult intestine,
the aim of the present study was to investigate the cellular
localization, distribution, and quantitative evaluation of c-Ret
in the adult human intestine, using immunohistochemistry
and immunofluorescence techniques in order to identify the
cell types derived from neural crest that persist in the adult
ENS. A double immunofluorescence procedure has been
carried out to examine the colocalization of c-Ret marker
with PGP9.5 (neuronal marker), with glial fibrillary acidic
protein (GFAP) (glial marker), and with c-Kit (interstitial cell
of Cajal marker).
2. Materials and Methods
Thematerial included in our study was obtained from intesti-
nal biopsies taken during endoscopic examination from 12
patients with different digestive pathologies (the average age
was 46 years; range 31–68). None of the patients included
in the study have bowel level affectation. The use of human
tissues was approved by the Ethics Committee for Clinical
Investigation of Aragon (CEICA; ICS08/0082), Zaragoza,
Spain.
Intestinal biopsy specimens were fixed in 10% neutral
buffered formalin, embedded in paraffin, cut, and processed
for immunohistochemistry.
2.1. Immunohistochemistry. The intestinal samples were fixed
for 6 hours with formol saline solution at 10% pH 7. Immuno-
histochemical staining was performed on paraffin sections
with 5 𝜇m of thickness using the immunohistochemistry
EnVision (Dako) method. The primary antibody used in this
study was the anti-Ret monoclonal antibody (clone RET01,
dilution 1 : 50, Affinity BioReagents, ABR). This antibody
was diluted with Dako diluent (S2022). The tissue sections
were deparaffined in xylene (10min twice) and rehydrated
in a graded ethanol series up to distilled water. Prior to all
assays, for heat-induced antigen retrieval, the samples were
treated for 6 minutes in an 800W microwave oven with
a 10% citrate buffer (Dako S2031) in distilled water and at
360W for 5 additional minutes. After washing twice with
PBS, for 3minutes, the sectionswere treatedwith endogenous
peroxidase blocking (Dako S2001) for 20 minutes, washed in
distilled water, and treated with the blocking buffer [100mL
PBS, 2mL triton X100, 0.25mL BSA (A4503 SIGMA)], for
3 minutes. The blocking was repeated for a second time.
The sections were incubated with the primary antibody
solution for 30 minutes followed by rinsing in PBS, for 3
minutes. The visualization was made by incubating with an
Envision peroxidase-based visualization kit (Dako K5007)
over a period of 30 minutes, washed twice in PBS, for 3
min according to manufacturer’s directions. To confirm the
presence of immunocomplexes, 3,3󸀠-diaminobenzidine was
used as chromogene and hydrogen peroxide as substrate.The
samples were washed twice in distilled water, contrasted with
Mayer’s haematoxylin for 7 minutes, washed in tap water
for 15 minutes, dehydrated in a graded series of ethanol,
cleared in xylene, and coverslipped with DPX. Digital micro-
scope images were captured by means of an Olympus BX
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software: ImageJ: Image Processing and Analysis in Java
available from http://rsb.info.nih.gov/ij/.
2.2. Counting Methods. The immunolabelled neurons were
quantified in a random intestinal sample of 3 cm in length
from each patient. 30 areas per region were studied from
each sample. The total number of ganglia (myenteric and
submucosal ganglia) and the total number of the c-Ret
positive cells, compared to total morphologically recognized
neurons, were counted.
Cells were counted by two independent investigators. If
the cell count differed by 10%, a third investigator then ana-
lyzed the samples. The final cell count was the mathematical
average of the independent cell counts. To minimize errors,
only those neurons in which the nucleus was clearly visible
were confirmed as positive controls.
2.3. Immunofluorescence. The expression and distribution of
proteins were studied by the indirect immunofluorescence
staining method for anti-Ret monoclonal antibody (clone
RET01, dilution 1 : 50, Affinity BioReagents, ABR), polyclonal
rabbit anti-glial fibrillary acidic protein (GFAP, dilution
1 : 100, Dako), polyclonal rabbit anti-PGP 9.5 (dilution 1 : 350,
Dako), polyclonal rabbit anti-human c-Kit (dilution 1 : 50,
Dako), goat anti-mouse IgG (HL) Alexa Fluor 488 (dilution
1 : 1000; Molecular Probes Invitrogen), and goat anti-rabbit
IgG (H+L) Alexa Fluor 546 (dilution 1 : 1000; Molecular
Probes Invitrogen).
The antibodies were diluted in Dako (S2022) diluent.
Tissue sections were deparaffined in xylene (10 minutes
twice) and rehydrated in a graded ethanol series up to
distilled water. Before all assays, for heat-induced antigen
retrieval, the samples were treated during 6 minutes in an
800W microwave oven with 10% citrate buffer (Dako S2031)
in distilled water and at 360 W for 5 additional minutes.
After washing three times with PBS, for 5 minutes, the
sections were treated with blocking buffer [100mL PBS, 2mL
triton X100, 0.25mL BSA (A4503 SIGMA)] for 20 minutes.
The blocking was repeated for a second time. Sections were
incubated with the primary antibody solution for 20 hours
followed by three rinses in PBS for 5 minutes. The visualiza-
tion was made with Alexa Fluor for 90 minutes, and then the
sections werewashed in PBS three times for 10 minutes and
incubated with 5𝜇M of DRAQ5 (Biostatus, Leicestershire,
UK) to counterstain the nuclei. Finally, cover slips were then
mounted in Mowiol Sigma-Aldrich, Deisenhofen, Germany)
and cell staining was documented using Leica TCS SL Laser
Scanning Confocal Microscope.
2.4. Statistical Analysis. Data are expressed as mean ± SEM.
Differences were analyzed by Student’s 𝑡-test. 𝑃 < 0.05 was
considered significant (∗), 𝑃 < 0.01 very significant (∗∗), and
𝑃 < 0.001 extremely significant (∗∗∗).
3. Results
3.1. c-Ret Immunoreactivity in Myenteric and Submucosal
Plexus. Intense c-Ret immunoreactivity was detected in all
cases studied of adult human intestine. c-Ret immunoreac-
tivity was positive in the myenteric and submucosal ganglia,
although significant differences between themwere found. In
the myenteric ganglia, only a few cells inside the ganglia were
labelled (Figure 1(a)), while in the submucosal ganglia most
cells were labeled (Figure 1(b)). On average, 32 myenteric
ganglia (range 22–42) and 36 submucosal ganglia (range 19–
54) per sample were counted. The total number of myenteric
neurons counted in this study was 4.284, 12.9% of which
showed c-Ret positivity. However, in the submucosal plexus,
the total number of neurons counted was 1.486; 58% were c-
Ret positive.There are significant differences between the two
plexuses (Figure 1(c)).
3.2. PGP9.5, GFAP, and c-Kit Immunodetection in Adult
Enteric Neurons. We performed a double immunofluores-
cence technique to assess coexpression of c-Ret/PGP9.5,
c-Ret/GFAP and c-Ret/c-Kit. PGP9.5-immunoreactive cells
appeared within myenteric ganglia (Figures 2(a)-1 and 2(b)-
1), GFAP-ir labelled cells appeared within myenteric ganglia
and around neurons (Figure 2(c)-1), and c-Kit labelled cells
appeared around myenteric ganglia (Figure 2(d)-1). In the
adult intestine, some of c-Ret-positive cells also exhibited
PGP9.5-ir.The colocalization of PGP9.5 and c-Ret was prefer-
entially intense in enteric neurons with oval morphology and
mostly peripherally localized in the ganglion (Figure 2(a)-3).
In contrast, there was no colocation in other subpopulations
of larger neurons with wide cytoplasm (Figure 2(b)-3). In
neither case studied, did we observe colocalization with
GFAP, glial cells marker (Figure 2(c)-3), and c-Kit, selective
marker of Interstitial cells of Cajal (Figure 2(d)-3).
The pattern of c-Ret expression observed with optical and
confocalmicroscopywas similar (Figures 2(a)-2, 2(b)-2, 2(c)-
2, and 2(d)-2).
4. Discussion
Thetyrosine kinase receptor c-Ret in associationwith another
receptor GDNFR-𝛼 (GDNFR𝛼-1) transduces GDNF medi-
ated signal, which seems to be one of the neurotrophic factors
related toALS [6–12].Thephosphorylation of several tyrosine
residues of c-Ret, a crucial step in the intracellular signal
pathway [6, 13], is thought to be altered in ALS [5].
c-Ret is expressed during the embryonic period as a
signal for the development of neurons in the enteric nervous
system [12, 14–19].There are no previous immunohistochem-
ical studies to confirm the presence of c-Ret (neural crest
marker) in the normal adult human gastrointestinal tract,
which would be interesting as an extrapolated model to ALS
patients.
An immunohistochemical study published was the only
one to show the existence of c-Ret positive neurons in the
myenteric plexus of adult rats. No positive neurons were
described in the submucosal plexus [38].
Although some myenteric neurons in humans have been
characterized based on morphology, projections, and neuro-
chemical staining [39–41], the subtypes of neurons present
in the ENS of any region of the adult human gastrointestinal
tract have not yet been systematically catalogued [42]. These
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Figure 1: Immunocytochemical localization of the c-Ret receptor tyrosine kinase in the myenteric 1(a) and submucosal plexus 1(b). Human
adult normal duodenum. Note that only the cytoplasm of some neurones appears labelled. 168 × 62mm (300 × 300DPI). Histogram showing
percentage of Ret positive-neurons. ∗∗∗𝑃 = 0.001 by Student’s 𝑡 test 1(c).
c-Ret positive neurons could be a specific neuronal subpopu-
lation of the enteric ganglia, whose functional role should be
studied. At this step we wonder about the potential function
of these neurons in the ENS.
Given the additional fact that intestinal smooth muscle
cells might even be a major source of GDNF, modulation
and/or promotion of their own smooth muscle innervation
in postnatal period might involve c-Ret receptors in adult
enteric neurons [38]. However, a neuroprotective role (by
mediating GDNF through the GFR𝛼1/c-Ret receptor com-
plex) as described for cerebellar Purkinje cells cannot be ruled
out [43].
Sharkey and Parr (1996) revised the literature on this issue
addressing the question about the enteric nature of these
neurons, taking into account that these cells are postmitotic.
These authors suggested that, since cell division in adult
neurons was unlikely, the possible explanation for neuron
addition in adulthood was a potential precursor nature of
these cells in myenteric ganglia and their capability of late
proliferation into adult neurons [44]. Although numerous
experimental models have suggested the existence of neuro-
genesis in the adult ENS, these cells have not been identified
in vivo [45–48].These cells could in situ present immunohis-
tochemical characteristics according to the embryonic origin
of the neural crest. Therefore, our results suggested that the
positive c-Ret neurons could answer this supposition.
On the other hand, Stemple and Anderson (1992) isolated
postmigratory neural crest cells from fetal rat gut usingc-Ret
and examined the developmental and proliferative capacities
of these cells using a clonal culture system [49]. Many of
the c-Ret positive cells divide symmetrically to generate
small clones containing only neurons and consequently;
they suggested that these c-Ret positive cells are committed
neuronal progenitors [30].
Therefore, it has been demonstrated that during the
tissue repair process, possible recapitulation of embrionary
development takes place. Geuna et al. have suggested that
NCCs, besides driving the development of many different
tissue and organs during development, can play a role also in
the postdevelopmental period of animal life because some of
the migratory elements persist as a peripherical reserve pool
of multipotent stem cells that can undergo late differentiation
into mature cells [50].
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Figure 2: Confocal microscopy. PGP9.5-ir, GFAP-ir, and c-Kit-ir cells in column 1, rows (a) and (b), (c), and (d), respectively; c-Ret-ir in
column 2 and merged images in column 3. Example of PGP9.5/c-Ret colocalization; adult enteric neurons labelled with PGP9.5 (a)-1, c-Ret
(a)-2, and merged image (a)-3. However, this colocalization does not appear to always occur; PGP9.5-ir neurons (b)-1 does not colocalize
with c-Ret neurons (b)-2 within the same ganglia (b)-3. GFAP-ir (c)-1 and c-Ret-ir cells (c)-2 are distinct cells (c)-3. Also, c-Kit-ir cells (d)-1
are c-Ret negatives (d)-2. Overlay image shows no colocalization between the two proteins (d)-3. Nuclear staining (blue). The scale bar is
20 𝜇m in length and applies to all images. 168 × 228 (300 × 300 DPI).
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We report immunohistochemical evidence for the pres-
ence of a group of adult enteric neurons stained with neural
crest marker, c-Ret, in the normal adult duodenum. c-
Ret was located in the myenteric and submucosal gan-
glia of the adult human duodenum and is expressed in
some enteric neurons since it colocalized with pan-neuronal
marker PGP9.5. Indeed, colocalization was more frequent
in oval enteric neurons located peripherally in the ganglion,
which suggested that c-Ret function is required not only
during early foetal stages but also in the mature human
ENS of the gut. The positivity to c-Ret may be indicative
of different stages of neuronal maturation and, therefore,
may be involved in adult enteric neurogenesis. We also
suggest, like other authors, that multipotent NCCs coexist
with differentiated cell types. Further studies are needed to
study in depth the nature of these cells and their potential
role in neurodegenerative diseases, such as ALS, could shed
light on new molecular pathways possibly affected under
neurodegenerative progression.
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